PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
61.73
Similar ESG score to SGMO's 61.93. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
60.13
Environmental score 1.1-1.2x SGMO's 56.11. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
62.05
Social score 90-95% of SGMO's 67.29. Bill Ackman would demand clear social improvement catalysts.
63.00
Similar governance score to SGMO's 62.39. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.